Clinical Efficacy of Conventional Heparin Anticoagulation Combined with Apixaban in the Treatment of Patients with Cerebral Venous Thrombosis and Its Effect on Serum D-Dimer and FIB Expression

Table 3

Adverse event analysis in the two groups.

	Standard group ()	Research group ()
Recurrence	0 (0.00)	0 (0.00)	—	—
Intracranial hemorrhage	3 (3.16)	2 (3.23)	0.441	0.659
Gastrointestinal bleeding	2 (2.11)	1 (1.61)	0.376	0.707
Venous thrombosis	3 (3.16)	1 (1.61)	0.082	0.934
Thrombocytopenia	2 (2.11)	1 (1.61)	0.376	0.707
Abdominal discomfort	3 (3.16)	2 (3.23)	0.441	0.659
Elevated liver enzymes	1 (1.05)	0 (0.00)	Fisher	>0.999
Depression	7 (7.37)	5 (4.84)	0.113	0.737
Total incidence	21 (22.11)	12 (19.35)	0.171	0.679